CardioDx announces plans to price initial public offering of stock

BofA Merrill Lynch and Jefferies are the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., Oct. 11 - CardioDx, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission.

BofA Merrill Lynch and Jefferies are the joint bookrunning managers. Piper Jaffray and William Blair are the co-managers.

Proceeds will be used for working capital, to cover operating losses, to conduct additional clinical and marketing activities, for research and development and for general corporate purposes.

The molecular diagnostics company is based in Palo Alto, Calif. It intends to list its common stock on the Nasdaq under the symbol "CDX."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.